Pharmaceutical composition with function of treating polycystic ovary syndrome

A technology of polycystic ovary and composition, which is applied in the field of pharmaceutical composition and its preparation with the effect of treating polycystic ovary syndrome, and can solve difficult problems such as radical cure

Active Publication Date: 2011-08-10
侯凤祥
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, Western medicine for the treatment of polycystic ovary sy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition with function of treating polycystic ovary syndrome
  • Pharmaceutical composition with function of treating polycystic ovary syndrome
  • Pharmaceutical composition with function of treating polycystic ovary syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0315] Embodiment 1: pharmaceutical composition capsule of the present invention

[0316] Astragalus 500g Poria 300g Atractylodes 300g

[0317] Epimedium 300g Salvia 100g.

[0318] Take the above-mentioned raw materials, and extract Danshen with 6 weight times of 90% ethanol under reflux for 2 times, each time for 1 hour, combine the extracts, filter, recover ethanol from the filtrate, and set aside; the other four herbs of Astragalus, Poria, Epimedium and Atractylodes Add 8 times the weight of water to soak for 1 hour, decoct 2 times, 2 hours each time, filter, combine the filtrate, combine with the above standby liquid, concentrate into a thick paste with a density of 1.2-1.5 at room temperature, dry, and grind into fine powder , adding conventional auxiliary materials, made into 1000 capsules, each 0.35g, orally 2-3 times a day, 2-4 capsules each time.

Embodiment 2

[0319] Embodiment 2: pharmaceutical composition tablet of the present invention

[0320] Astragalus 700g Poria 150g Stir-fried Atractylodes 150g

[0321] Epimedium 450g Salvia 150g.

[0322] Get above-mentioned raw material, add conventional adjuvant, make pharmaceutical composition tablet of the present invention according to conventional process.

Embodiment 3

[0323] Embodiment 3: pharmaceutical composition granule of the present invention

[0324] Astragalus 300g Poria 450g Atractylodes 450g

[0325] Epimedium 150g Salvia 80g.

[0326] Take the above-mentioned raw materials, and extract Danshen with 6 weight times of 90% ethanol under reflux for 2 times, each time for 1 hour, combine the extracts, filter, recover ethanol from the filtrate, and set aside; the other four herbs of Astragalus, Poria, Epimedium and Atractylodes Add 8 times the weight of water to soak for 1 hour, decoct 2 times, 2 hours each time, filter, combine the filtrate, combine with the above standby liquid, concentrate into a thick paste with a density of 1.2-1.5 at room temperature, dry, and grind into fine powder , add conventional auxiliary materials, and prepare the pharmaceutical composition granules of the present invention according to conventional methods.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition with the function of treating polycystic ovary syndrome, a preparation method and a quality detection method. The pharmaceutical composition preparation of the invention uses astragalus mongholicus, herba epimedii, rhizoma atractylodis, tuckahoe and red sage root as raw material drugs; various types of preparation can be prepared through a special preparation method. The pharmacodynamics experiment indicates that the pharmaceutical composition can reduce blood sugar and insulin, decrease the content of serum testosterone, and have importantsignificance for treating the polycystic ovary syndrome. A prescription sieving experiment indicates that, when the polycystic ovary syndrome is treated, the optimal dose level range of the pharmaceutical composition is: 50g Astragalus mongholicus, 30g rhizome, 30g tuckahoe, 30g herba epimedii, and 10g the red sage root.

Description

field of invention [0001] The invention discloses a pharmaceutical composition, a preparation method and a quality detection method thereof, and particularly relates to a pharmaceutical composition capable of treating polycystic ovary syndrome, a preparation method and a quality detection method thereof. Background technique [0002] Menstrual disorders, amenorrhea, anovulation, hirsutism, obesity, infertility combined with bilateral ovary enlargement and cystic changes are called polycystic ovary syndrome. Patients may have the above typical symptoms, or only some symptoms, but infertility due to ovulation disorders is the main clinical manifestation of polycystic ovary syndrome. [0003] The exact cause of polycystic ovary syndrome is unknown, but it is currently believed that the ovaries produce too much androgen, and the excessive production of androgen is the result of the synergistic effect of various endocrine system dysfunctions in the body. Polycystic ovary syndrom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/537A61K9/16A61K9/20A61K9/00A61K9/48G01N30/90G01N30/36A61P15/00A61P3/10A61P5/48A61P5/28
Inventor 侯凤祥
Owner 侯凤祥
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap